Automated Insulin Tech Empowers T1D Marathoners
Automated insulin delivery tech helps T1D runners manage glucose during marathons, enhancing safety and performance.
- Latest
- Trending
Automated insulin delivery tech helps T1D runners manage glucose during marathons, enhancing safety and performance.
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Health systems must integrate new technologies and AI to overcome rising challenges and improve care experiences.
Discover Piper Sandler's eight high-quality defensive biotech stocks poised to thrive in volatile markets.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Artificial Intelligence in Ultrasound Imaging Market to grow from USD 889.16 million in 2023 to USD 1733.08 million by 2031 ...
The growing AI in drug discovery market is driven by the increasing amount of data in drug development. However, restraints ...
Discover the lucrative world of biotech stocks in the ever-evolving healthcare industry. Navigate risks and rewards to maximize your investment ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.